Cadila buys remaining 30 pc share in Zydua Pharmaceuticals

MUMBAI: Drug major, Cadila Healthcare Ltd on Wednesday said it has purchased the remaining 30 per cent shares for an undisclosed amount in its US-based joint venture, Zydus Pharmaceuticals from its partners.

Zydus Pharmaceuticals is a joint venture of Cadila through its Irish subsidiary in which it already had 70 per cent stake and after the deal the US-based company became a 100 per cent subsidiary of Cadila Healthcare, the company said.